Replay available

Trevi Therapeutics, Inc. (TRVI) Q1 2026 Earnings Call

Trevi Therapeutics, Inc. (NASDAQ: TRVI) Q1 2026 earnings conference call, held 2026-05-05. Replay captured from the company's public earnings webcast.

Tue, May 5, 2026 at 4:30 PMendedReplay
Trevi Therapeutics, Inc. (TRVI) Q1 2026 Earnings Call

Hosted by

Featured presenters

Jennifer Good

President and Chief Executive Officer

David Hastings

Chief Financial Officer

Dr. James Casella

Chief Development Officer

Farrell Simon

Chief Commercial Officer

Roana Ruiz

Analyst, Leerink Partners

Judah Frommer

Analyst, Morgan Stanley

Alexa Deamer

Analyst, Kantor Fitzgerald

William Wood

Analyst, V. Reilly Securities

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Trevi Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.035 Good afternoon and welcome to the Trevi Therapeutics first quarter 2026 earnings 00:00:05.035 -- 00:00:10.540 conference call. At this time, all participants are in a listen-only mode. 00:00:10.540 -- 00:00:14.884 After today's presentation, there will be an opportunity to ask questions. 00:00:14.884 -- 00:00:18.967 To ask a question during the session, you will need to press star 1-1 on your telephone. 00:00:18.967 -- 00:00:23.051 You will then hear an automated message advising your hand is raised. 00:00:23.051 -- 00:00:26.614 To withdraw your question, please press star 1-1 again. 00:00:26.614 -- 00:00:30.305 Please be advised that today's conference is being recorded. 00:00:30.305 -- 00:00:34.292 Various remarks that management makes during this conference call about the company's 00:00:34.292 -- 00:00:39.721 future expectations, plans, and prospects constitute forward-looking statements for purposes 00:00:39.721 -- 00:00:46.049 of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. 00:00:46.049 -- 00:00:51.279 Actual results may differ materially from those indicated by these forward-looking statements 00:00:51.279 -- 00:00:56.209 as a result of various important factors, including those discussed in the risk factors 00:00:56.209 -- 00:01:01.278 section of the company's most recent annual report on Form 10-K, which the 00:01:01.278 -- 00:01:06.569 company filed with the SEC on March 17, 2026, as 00:01:06.569 -- 00:01:10.214 updated by our subsequent filings. 00:01:10.214 -- 00:01:14.518 In addition, any forward-looking statements represent the company's views only as of 00:01:14.518 -- 00:01:19.704 today and should not be relied upon as representing the company's views as of any 00:01:19.704 ...